Trevena, Inc. Enters Research Collaboration with Merck & Co., Inc. To Identify Novel Biased Ligand Molecules

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc., the leader in the discovery and development of G-protein coupled receptor (GPCR) biased ligands, today announced the initiation of a research coll…
Read the full story: BioSpace.com Featured News